Matching slides 6,793
Current window 5,521-5,550
Pages 227
Rows per page 30
Framework: Fraud Exposureclear collectionreset all

Framework

5,521-5,550 of 6,793

filter-aware
175
The slide uses a 'villain_critique' approach by quoting an ex-employee to expose what the author considers to be fraudulent medical claims.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
176
The slide uses a table from a JAMA Surgery paper to highlight the mean donor age in the trial (45.9 years) as evidence of selection bias.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
181
The slide uses a combination of narrative summary and verbatim Q&A transcripts to highlight discrepancies between trial conditions and real-world usage.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
183
The slide uses direct quotes from a transplant surgeon to expose potential malpractice or dangerous usage patterns.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
185
The slide uses a 'villain' narrative style to frame the company's business practices as risky or non-compliant.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
189
The slide uses a Q&A transcript format to substantiate claims of fraud and kickbacks.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
191
The slide uses expert testimony to contradict the manufacturer's regulatory compliance claims.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
201
The slide uses a Q&A format to build a narrative of malpractice and dishonesty.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
208
The slide uses a 'villain' narrative structure to cast doubt on the company's operational standards.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
211
The slide uses a Q&A format to highlight the 'unusual' nature of the credentialing process, followed by a direct citation of the AOPO manual to suggest a violation of standard protocols.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
212
The slide uses a Q&A format to substantiate claims of regulatory circumvention.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
221
The slide uses visual evidence from the Internet Archive to contradict the company's attempt to distance itself from Macchiarini.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
225
The slide uses screenshots as evidence to link a medical professional to a controversial third-party platform.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
229
The slide uses a Q&A format to highlight a perceived ethical conflict between corporate procurement goals and clinical safety standards.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
234
The slide uses a Q&A format to substantiate claims of surgical incompetence and unethical organ distribution practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
235
The slide uses a Q&A format to highlight potential ethical concerns regarding data transparency in organ recovery.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
238
The slide uses direct quotes from former employees to support the claim of incompetence and lack of proper medical oversight.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
242
The slide uses a quote-based argument to challenge the company's stated quality control rationale.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
252
The slide uses direct quotes from KOLs to build a negative narrative around the company's business ethics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
263
The slide uses a Q&A format to highlight a specific allegation of corporate dishonesty.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
267
The slide uses a combination of summary text and direct interview transcripts to build a case of corporate misconduct.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
301
The slide uses direct quotes and Q&A transcripts to undermine the clinical value proposition of the TransMedics device.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
326
This slide functions as a 'villain critique' or 'fraud exposure' note, likely part of a short-seller research report.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
327
The slide uses direct quotes from former employees to build a case for corporate malfeasance and product failure.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
328
The slide uses a Q&A format to present testimony, highlighting specific instances of alleged misconduct.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
330
The slide uses direct quotes from former employees and industry peers to build a case against the reliability of the TransMedics OCS device.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
333
The slide uses visual evidence (images of livers and CT scans) to support the argument that machine perfusion causes lasting tissue damage.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
336
The slide presents a narrative of corporate deception regarding medical device performance.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
338
The slide uses a quote to highlight a perceived lack of transparency by the company.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
340
The slide uses a Q&A format to highlight a specific expert's negative experience with TransMedics equipment and corporate communication.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit